Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Pharma
Priovant secures 1st FDA nod in rare skin and muscle disease
Priovant Therapeutics has pushed its dual TYK2/JAK1 inhibitor across the FDA finish line, securing the asset its first nod in a rare skin disease.
Fraiser Kansteiner
Aug 27, 2026 9:30pm
More reductions for Pfizer as it tacks on $2.5B in cost savings
Aug 4, 2026 11:33am
Pfizer plots Litfulo vitiligo filings, pressuring Incyte, AbbVie
Jul 30, 2026 2:15pm
Sanofi reprimanded for disparaging Pfizer’s RSV vaccine
Jul 22, 2026 6:27am
Sanofi sues Pfizer, Moderna over mRNA patents
Jul 15, 2026 3:32pm
FDA expands Padcev-Keytruda combo to more MIBC patients
Jul 10, 2026 1:10pm
